HKND:NYE-Humankind Benefit Corporation - Humankind US Stock ETF (USD)

ETF | Others |

Last Closing

USD 31.295

Change

+0.11 (+0.35)%

Market Cap

USD 0.14B

Volume

600.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

-0.04 (-0.20%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

-0.33 (-0.58%)

USD 33.58B
DFAC Dimensional U.S. Core Equity 2..

-0.04 (-0.13%)

USD 27.95B
DTB DTB

-0.13 (-0.68%)

USD 26.58B
GBTC Grayscale Bitcoin Trust (BTC)

-0.75 (-1.22%)

USD 23.75B
JPST JPMorgan Ultra-Short Income ET..

+0.01 (+0.02%)

USD 23.30B
SGOV iShares® 0-3 Month Treasury B..

+0.01 (+0.01%)

USD 21.42B
AVUV Avantis® U.S. Small Cap Value..

-0.22 (-0.24%)

USD 11.36B
DFUV Dimensional US Marketwide Valu..

-0.20 (-0.50%)

USD 10.61B
DFAT Dimensional U.S. Targeted Valu..

-0.12 (-0.22%)

USD 9.96B

ETFs Containing HKND

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.96% 66% D+ 64% D
Dividend Return 0.34% 26% F 17% F
Total Return 7.30% 65% D 62% D
Trailing 12 Months  
Capital Gain 15.68% 60% D- 60% D-
Dividend Return 0.82% 12% F 8% B-
Total Return 16.50% 56% F 55% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.02% 56% F 44% F
Dividend Return 1.88% 53% F 36% F
Total Return 0.87% 44% F 21% F
Risk Return Profile  
Volatility (Standard Deviation) 6.69% 66% D+ 89% A-
Risk Adjusted Return 28.16% 54% F 50% F
Market Capitalization 0.14B 68% D+ 29% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.